These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 34818486)

  • 1. Treatment of Diabetes - To Pump or Not to Pump.
    O'Connell J; Nathan DM; O'Brien T; O'Keeffe DT
    N Engl J Med; 2021 Nov; 385(22):2092-2095. PubMed ID: 34818486
    [No Abstract]   [Full Text] [Related]  

  • 2. Putting brakes on insulin pump infusion to prevent hypoglycemia.
    Cengiz E
    J Diabetes Sci Technol; 2011 Sep; 5(5):1142-3. PubMed ID: 22027307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Insulin pump regulated by a glucose sensor; one step closer to closing the loop for type 1 diabetes patients].
    de Valk HW
    Ned Tijdschr Geneeskd; 2019 Sep; 163():. PubMed ID: 31556504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cost-effectiveness analysis of sensor-augmented insulin pump therapy and automated insulin suspension versus standard pump therapy for hypoglycemic unaware patients with type 1 diabetes.
    Ly TT; Brnabic AJ; Eggleston A; Kolivos A; McBride ME; Schrover R; Jones TW
    Value Health; 2014 Jul; 17(5):561-9. PubMed ID: 25128049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-time Continuous Glucose Monitoring During a Hyperinsulinemic-Hypoglycemic Clamp Significantly Underestimates the Degree of Hypoglycemia.
    Farrell CM; McNeilly AD; Hapca SM; McCrimmon RJ
    Diabetes Care; 2020 Oct; 43(10):e142-e143. PubMed ID: 32820010
    [No Abstract]   [Full Text] [Related]  

  • 6. Tools of the trade 2012.
    Cooper AA
    Diabetes Self Manag; 2012; 29(6):30, 32-4, 36-8 passim. PubMed ID: 23330471
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of Sensor-Augmented Pump Therapy with Predictive Low-Glucose Suspend Function on Glycemic Control and Patient Satisfaction in Adults and Children with Type 1 Diabetes.
    Beato-Víbora PI; Quirós-López C; Lázaro-Martín L; Martín-Frías M; Barrio-Castellanos R; Gil-Poch E; Arroyo-Díez FJ; Giménez-Álvarez M
    Diabetes Technol Ther; 2018 Nov; 20(11):738-743. PubMed ID: 30256132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Talking Points for Helping Your Type 1 Diabetes Patient Decide About Hybrid Closed Loop.
    Perkins BA; Cardinez N; Opsteen CF
    Can J Diabetes; 2020 Jun; 44(4):356-358. PubMed ID: 31866241
    [No Abstract]   [Full Text] [Related]  

  • 9. CGMs and insulin pumps. Is this dynamic duo the right choice for you?
    Neithercott T
    Diabetes Forecast; 2013 Jan; 66(1):48-55. PubMed ID: 23373086
    [No Abstract]   [Full Text] [Related]  

  • 10. Type 1 diabetes technology: advances and challenges.
    The Lancet Diabetes Endocrinology
    Lancet Diabetes Endocrinol; 2019 Sep; 7(9):657. PubMed ID: 31439271
    [No Abstract]   [Full Text] [Related]  

  • 11. Insulin pump therapy in pregnant women with type 1 diabetes mellitus.
    Roman G
    Rom J Intern Med; 2004; 42(2):465-8. PubMed ID: 15529637
    [No Abstract]   [Full Text] [Related]  

  • 12. A Mobile Application Guiding Patients With Type 1 Diabetes Using Sensor-Augmented Insulin Pump Therapy.
    Esvant A; Lefebvre MA; Campillo-Gimenez B; Lannes M; Delamarre D; Guilhem I; Poirier JY
    J Diabetes Sci Technol; 2016 Jul; 10(4):985-6. PubMed ID: 26902791
    [No Abstract]   [Full Text] [Related]  

  • 13. An integrated multivariable artificial pancreas control system.
    Turksoy K; Quinn LT; Littlejohn E; Cinar A
    J Diabetes Sci Technol; 2014 May; 8(3):498-507. PubMed ID: 24876613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does A1c Have to Change for Hypoglycemia Reduction?
    Renard E
    Diabetes Technol Ther; 2015 Aug; 17(8):527-9. PubMed ID: 25978209
    [No Abstract]   [Full Text] [Related]  

  • 15. Numerical and clinical precision of continuous glucose monitoring in Colombian patients treated with insulin infusion pump with automated suspension in hypoglycemia.
    Gómez AM; Marín Sánchez A; Muñoz OM; Colón Peña CA
    Endocrinol Nutr; 2015 Dec; 62(10):485-92. PubMed ID: 26531841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overnight closed-loop insulin delivery with model predictive control: assessment of hypoglycemia and hyperglycemia risk using simulation studies.
    Wilinska ME; Budiman ES; Taub MB; Elleri D; Allen JM; Acerini CL; Dunger DB; Hovorka R
    J Diabetes Sci Technol; 2009 Sep; 3(5):1109-20. PubMed ID: 20144424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment satisfaction and quality of life for an integrated continuous glucose monitoring/insulin pump system compared to self-monitoring plus an insulin pump.
    Rubin RR; Peyrot M
    J Diabetes Sci Technol; 2009 Nov; 3(6):1402-10. PubMed ID: 20144395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-Clinic Evaluation of the MiniMed 670G System "Suspend Before Low" Feature in Children with Type 1 Diabetes.
    Wood MA; Shulman DI; Forlenza GP; Bode BW; Pinhas-Hamiel O; Buckingham BA; Kaiserman KB; Liljenquist DR; Bailey TS; Shin J; Huang S; Chen X; Cordero TL; Lee SW; Kaufman FR
    Diabetes Technol Ther; 2018 Nov; 20(11):731-737. PubMed ID: 30299976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial.
    Ly TT; Nicholas JA; Retterath A; Lim EM; Davis EA; Jones TW
    JAMA; 2013 Sep; 310(12):1240-7. PubMed ID: 24065010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Incremental Benefits of the Predictive Low-Glucose Suspend Function Compared to the Low-Glucose Suspend Function as Automation Against Hypoglycemia in Sensor-Augmented Pump Therapy.
    Beato-Víbora PI; Gil-Poch E; Galán-Bueno L; Lázaro-Martín L; Arroyo-Díez FJ
    J Diabetes Sci Technol; 2018 Nov; 12(6):1241-1243. PubMed ID: 30058373
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.